Literature DB >> 8291252

Evolution of the nucleoprotein and matrix genes of wild-type strains of measles virus isolated from recent epidemics.

P A Rota1, A E Bloom, J A Vanchiere, W J Bellini.   

Abstract

To characterize the genetic properties of currently circulating strains of wild-type measles viruses, we constructed and sequenced cDNA clones of the nucleoprotein (N) and matrix (M) genes of wild-type strains isolated between 1958 and 1989. The N and M genes of wild-type isolates from the prevaccine era (before 1964) were highly related to each other and to the N and M genes of a currently used measles vaccine strain, Moraten. The N and M genes of these viruses differed by no more than 0.5% at the nucleotide level. In contrast, the N and M genes of wild-type viruses isolated between 1977 and 1989 showed genetic drift, with the greatest amount of drift occurring in the viruses isolated from recent cases in the United States. Overall, the M genes were slightly more conserved at the nucleotide level (2.6% nucleotide, 3.3% amino acid) than the N genes (4.8% nucleotide, 3.4% amino acid). Alignment of the predicted protein sequences of the N genes revealed two regions of amino acid heterogeneity. The evolutionary patterns for the N and M genes suggested that the wild-type viruses isolated in the United States in 1989 were more related to wild-type viruses isolated in the United Kingdom between 1983 and 1988 than to viruses isolated in the United States in 1983.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8291252     DOI: 10.1006/viro.1994.1086

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  28 in total

1.  Comparison of predicted amino acid sequences of measles virus strains in the Edmonston vaccine lineage.

Authors:  C L Parks; R A Lerch; P Walpita; H P Wang; M S Sidhu; S A Udem
Journal:  J Virol       Date:  2001-01       Impact factor: 5.103

Review 2.  Review of the temporal and geographical distribution of measles virus genotypes in the prevaccine and postvaccine eras.

Authors:  Michaela A Riddell; Jennifer S Rota; Paul A Rota
Journal:  Virol J       Date:  2005-11-22       Impact factor: 4.099

3.  Spontaneous mutation rate of measles virus: direct estimation based on mutations conferring monoclonal antibody resistance.

Authors:  S J Schrag; P A Rota; W J Bellini
Journal:  J Virol       Date:  1999-01       Impact factor: 5.103

4.  Characterization of a natural mutation in an antigenic site on the fusion protein of measles virus that is involved in neutralization.

Authors:  J Fayolle; B Verrier; R Buckland; T F Wild
Journal:  J Virol       Date:  1999-01       Impact factor: 5.103

5.  Nucleotide sequences of the M gene of prevailing wild measles viruses and a comparison with subacute sclerosing panencephalitis virus.

Authors:  C Kai; K Yamanouchi; H Sakata; N Miyashita; H Takahashi; F Kobune
Journal:  Virus Genes       Date:  1996       Impact factor: 2.332

6.  Molecular epidemiology and changing distribution of genotypes of measles virus field strains in Japan.

Authors:  Y Katayama; K Shibahara; T Kohama; M Homma; H Hotta
Journal:  J Clin Microbiol       Date:  1997-10       Impact factor: 5.948

7.  Characterization of measles virus strains causing SSPE: a study of 11 cases.

Authors:  L Jin; S Beard; R Hunjan; D W G Brown; E Miller
Journal:  J Neurovirol       Date:  2002-08       Impact factor: 2.643

8.  Measles virus genotyping by nucleotide-specific multiplex PCR.

Authors:  Jacques R Kremer; Fred Fack; Christophe M Olinger; Mick N Mulders; Claude P Muller
Journal:  J Clin Microbiol       Date:  2004-07       Impact factor: 5.948

9.  Analysis of matrix protein gene nucleotide sequence diversity among Newcastle disease virus isolates demonstrates that recent disease outbreaks are caused by viruses of psittacine origin.

Authors:  B S Seal
Journal:  Virus Genes       Date:  1995       Impact factor: 2.332

10.  Molecular epidemiology of measles viruses in the United States, 1997-2001.

Authors:  Paul A Rota; Stephanie L Liffick; Jennifer S Rota; Russell S Katz; Susan Redd; Mark Papania; William J Bellini
Journal:  Emerg Infect Dis       Date:  2002-09       Impact factor: 6.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.